These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23419233)

  • 1. Drug interactions in the treatment of depression in patients receiving β-blocker drugs.
    Andrade C
    J Clin Psychiatry; 2013 Jan; 74(1):e75-8. PubMed ID: 23419233
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
    Alexandrino-Silva C; Nadalini Mauá FH; de Andrade AG; de Toledo Ferraz Alves TC
    J Psychopharmacol; 2008 Mar; 22(2):214-6. PubMed ID: 18208934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients.
    Peñas-Lledó EM; Trejo HD; Dorado P; Ortega A; Jung H; Alonso E; Naranjo ME; López-López M; Llerena A
    Mol Psychiatry; 2013 Jan; 18(1):8-9. PubMed ID: 22733128
    [No Abstract]   [Full Text] [Related]  

  • 6. Likelihood to be helped or harmed can assist in clinical decision-making.
    Citrome L
    J Clin Psychiatry; 2011 Feb; 72(2):261-2; author reply 262. PubMed ID: 21382311
    [No Abstract]   [Full Text] [Related]  

  • 7. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible effect of beta-blocker on the prevention of ventricular tachycardia during electroconvulsive therapy.
    Usui C; Hatta K; Yokoyama T; Oshima M; Ito M; Shibata N; Arai H
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):623. PubMed ID: 18950387
    [No Abstract]   [Full Text] [Related]  

  • 9. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
    Gitlin MJ
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta blocker inhibits tricyclic metabolism.
    Gillette DW; Tannery LP
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):223-4. PubMed ID: 7908665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depressive disorder treatment guidelines in China.
    Zhang M
    J Clin Psychiatry; 2010; 71 Suppl E1():e06. PubMed ID: 20371033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
    Parwani P; Ryan J
    Circ Heart Fail; 2012 Nov; 5(6):819. PubMed ID: 23170021
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.
    Thürmann PA; Haack S; Werner U; Szymanski J; Haase G; Drewelow B; Reimann IR; Hippius M; Siegmund W; May K; Hasford J
    Clin Pharmacol Ther; 2006 Nov; 80(5):551-3. PubMed ID: 17112812
    [No Abstract]   [Full Text] [Related]  

  • 17. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
    Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
    Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions between metoprolol and antidepressants].
    Molden E; Spigset O
    Tidsskr Nor Laegeforen; 2011 Sep; 131(18):1777-9. PubMed ID: 21946596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 20. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.